CD19 Universal CAR-γδT Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 Universal CAR-γδT Cells, covering 2025-01-08 to 2025-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus [Phase 1, Phase 2]